After Zoe Ball shared a before and after of her fat-melting massage treatment, Mirror writer Niamh Kirk decided to try it out to see if the results really are as good as they looked ...

If you or any member of your family is sensitive to dust and other allergens, you may be wondering if there’s a way to k ...

Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification ...

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adults and adolescents with ...

The FDA has approved Dupixent for the treatment of patients aged 12 years and older with CSU who remain symptomatic despite H1 antihistamine treatment.

Some people experience a flare-up of hives that goes away on its own. Other people may have hives that come and go daily. Hives are itchy, raised bumps on the skin. Doctors diagnose chronic hives ...

Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients 12 years and older whose hives ...

Dupixent, which was rejected by the FDA for chronic spontaneous urticaria in October 2023, is now approved as the first new ...

Just thinking about poison ivy can make you itch. Blistering rashes on your arms and ankles, oozing bumps between your fingers and eyelid-swelling exposures are all-too-familiar summer hazards.

some patients may have concomitant chronic inducible urticaria. For type IIb disease, patients are more often women, exhibit frequent comorbid autoimmune diseases, have low total IgE levels ...

The FDA has approved Dupixent as the first new targeted therapy in over ten years for chronic spontaneous urticaria in patients aged 12 and older who remain symptomatic despite antihistamine treatment ...